NDM-1 polymicrobial infections including Vibrio cholerae

The Lancet

Volumn 380, Issue 9850, 2012, Pages 1358-

  Darley, Elizabeth ^a   Weeks, Janis ^b   Jones, Lim ^b   Daniels, Victoria ^c   Wootton, Mandy ^c   MacGowan, Alasdair ^a   Walsh, Timothy ^b  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c PUBLIC HEALTH WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; COTRIMOXAZOLE; MEROPENEM; NDM 1 PROTEIN; PROTEIN; TEICOPLANIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BLOOD CULTURE; CASE REPORT; CHOLERA; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTRIC BURN; FEVER; FLIGHT; HUMAN; HYPOTENSION; INDIA; INTENSIVE CARE; MALE; NOTE; PRIORITY JOURNAL; RESUSCITATION; VIBRIO CHOLERAE;

EID: 84867284733     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60911-8     Document Type: Article

References (5)

1. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
2. Andrews JM, Howe RA. For the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 10). J Antimicrob Chemother 2011; 66: 2726-57.
3. European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org/ clinical-breakpoints/ (accessed April 4, 2012).
4. Magnusson MR, Pegg SP. Vibrio cholerae non-01 primary septicaemia following a large thermal burn. Burns 1996; 1: 44-47.
5. Jabeen K, Siddiqui J, Zafar A, et al. Vibrio cholerae 01 bacteremia in Pakistan: analysis of eight cases. Trans R Soc Trop Med Hyg 2010; 104: 563-65.